TAMPA, Fla. & MINNEAPOLIS, Minn.--(BUSINESS WIRE)--Biovest International, Inc. (Pink Sheets: BVTI) today announced that the Company will present the ongoing commercial development of the Company’s personalized cancer vaccine, BiovaxID®, on June 22nd at the Active Immunotherapeutics Forum 2010 in Barcelona, Spain.
